Literature DB >> 7903953

In vivo evidence of enhanced guanylyl cyclase activation during the hyperdynamic circulation of acute liver failure.

F Schneider1, P Lutun, K Boudjema, P Wolf, J D Tempé.   

Abstract

Nitric oxide and atrial natriuretic peptides are the main activators of guanylyl cyclases, which transform GTP into cyclic GMP and thereby contribute to the decrease of vascular tone. To investigate the increase, if any, of plasma cyclic GMP concentrations in human patients with hyperdynamic circulation resulting from acute liver failure and to ascertain whether guanylyl cyclase activation is involved in the decline of systemic vascular resistance that occurs in this pathophysiological condition, we simultaneously recorded hemodynamic data and cyclic GMP levels in patients with fulminant liver failure before and after liver transplantation and in normokinetic patients undergoing abdominal nonseptic surgery. We also compared these data with those recorded in patients with hyperkinetic shock resulting from gram-negative sepsis or nitric oxide-independent vasomotor agent (carbamate) over-dose. In all these patients we simultaneously studied kidney function, platelet counts and atrial natriuretic peptides. Patients with fulminant liver failure had higher cyclic GMP concentrations than did control patients undergoing abdominal surgery (11.02 +/- 1.55 pmol.ml-1 vs. 1.77 +/- 0.18 pmol.ml-1, p < 0.001). At similar heart-loading conditions these concentrations were lower than those in gram-negative septic shock (18.2 +/- 1.35 pmol.ml-1, p < 0.05) but higher than those in carbamate-induced shock (3.6 +/- 0.7 pmol.ml-1, p < 0.01). In addition, cyclic GMP concentrations significantly decreased from the fulminant liver failure period to the posttransplantation period, although atrial natriuretic peptide levels did not change significantly and kidney function worsened.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7903953

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

1.  Reversal of the haemodynamic features of acute liver failure by methylene blue.

Authors:  P V McGinn
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

2.  Nitric oxide and L-arginine metabolism in a devascularized porcine model of acute liver failure.

Authors:  Vikram Sharma; Gabriella A M Ten Have; Lars Ytrebo; Sambit Sen; Christopher F Rose; R Neil Dalton; Charles Turner; Arthur Revhaug; Hans M H van-Eijk; Nicolaas E P Deutz; Rajiv Jalan; Rajeshwar P Mookerjee; Nathan A Davies
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-15       Impact factor: 4.052

3.  Enhanced urinary excretion of cGMP in liver cirrhosis. Relationship to hemodynamic changes, neurohormonal activation, and urinary sodium excretion.

Authors:  C M Fernández-Rodriguez; J Prieto; J Quiroga; J M Zozaya; A Andrade; C Rodriguez-Ortigosa
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

4.  Cyclooxygenase-2 and inducible nitric oxide synthase in omental arteries harvested from patients with severe liver diseases: immuno-localization and influence on vascular tone.

Authors:  Antonia Tabernero; Francis Schneider; Maria Assunta Potenza; Voahanginirina Randriamboavonjy; Sylvette Chasserot; Philippe Wolf; Delia Mitolo-Chieppa; Jean-Claude Stoclet; Ramaroson Andriantsitohaina
Journal:  Intensive Care Med       Date:  2003-01-15       Impact factor: 17.440

Review 5.  Altered modulation of soluble guanylate cyclase by nitric oxide in patients with liver disease.

Authors:  R Corbalán; C Montoliu; M D Miñana; J A Del Olmo; M A Serra; L Aparisi; J M Rodrigo; V Felipo
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

6.  Intracellular conversion of environmental nitrate and nitrite to nitric oxide with resulting developmental toxicity to the crustacean Daphnia magna.

Authors:  Bethany R Hannas; Parikshit C Das; Hong Li; Gerald A LeBlanc
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

7.  Acute liver failure: Summary of a workshop.

Authors:  William M Lee; Robert H Squires; Scott L Nyberg; Edward Doo; Jay H Hoofnagle
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

8.  Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure.

Authors:  William M Lee; Linda S Hynan; Lorenzo Rossaro; Robert J Fontana; R Todd Stravitz; Anne M Larson; Timothy J Davern; Natalie G Murray; Timothy McCashland; Joan S Reisch; Patricia R Robuck
Journal:  Gastroenterology       Date:  2009-06-12       Impact factor: 22.682

9.  Role of N-acetylcysteine treatment in non-acetaminophen-induced acute liver failure: A prospective study.

Authors:  Tauseef Nabi; Sumaiya Nabi; Nadeema Rafiq; Altaf Shah
Journal:  Saudi J Gastroenterol       Date:  2017 May-Jun       Impact factor: 2.485

Review 10.  Postreperfusion syndrome during liver transplantation.

Authors:  Sung-Moon Jeong
Journal:  Korean J Anesthesiol       Date:  2015-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.